Loading...

Seres Therapeutics, Inc.

MCRB•NASDAQ
Healthcare
Biotechnology
$15.44
$0.91(6.26%)

Seres Therapeutics, Inc. (MCRB) Stock Chart & Performance Analysis

Explore Seres Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
8.32%
5-Day Change
-14.62%
1-Month Change
-20.05%
3-Month Change
-31.23%
6-Month Change
-24.60%
Year-to-Date (YTD) Change
-31.15%
1-Year Change
-15.78%
3-Year Change
-91.11%
5-Year Change
-83.65%
All-Time (Max) Change
-98.87%

Analyzing Seres Therapeutics, Inc. (MCRB) Trends Across Multiple Time Frames

Seres Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Seres Therapeutics, Inc. stock shows 8.32% 1-day change, indicating immediate volatility, while its 5-day change of -14.62% suggests a broader trend. Over a 1-month period, a -20.05% drop could signal a pullback, whereas a 3-month decline of -31.23% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -24.60% and a YTD drop of -31.15% might concern investors, but a 1-year loss of -15.78% and a 3-year drop of -91.11% could indicate resilience. The 5-year surge of -83.65% highlights weak historical growth, while the all-time return of -98.87% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;